I took some profit when SP went up to over $1 but still holding...

First 5 Last

Share
Profile

Follow
Quakers

744 Posts.

15

17/12/16

15:50

Post #: 21411158
Share

Originally posted by justcurious ↑

It looks to me like MM is expecting Merck to continue running with VLA into phase 3. I just revisited the ABC interview in June 2016 (http://www.abc.net.au/news/2016-06-03/extended-interview-with-dr-malcolm-mccoll/7476824) and he says at the 6 minute point "and of course if we saw the results we were hoping to see in the Merck collaboration then we know Merck would want to continue to fund and increase investment". My interpretation is that Merck would push forward, and pay for, Phase 3 trials. I also note that at the AGM MM said something like "and the price just went up" - talking about the results publicised in October, so my take is that Cavatak has exceed "there results we were hoping to see".

He also says that the differentiator for the big IO drugs (Keytruda, Opdivo, Yervoy, etc) is the best combination, and it seems to be a conscious effort to not have partnered with everybody, so as to own as much as possible of the IP.

It seems the future is rosy, just need to be patient!

Expand

I took some profit when SP went up to over $1 but still holding on to some parcels. The clinical trials have been positive, the melanoma area is progressing quite well, but I also believe the bladder trial is another ace that the VLA is holding. Truly a bright future for VLA.

VLA Price at posting: $1.21 Sentiment: Hold Disclosure: Held
8 Upvote

0 Great analysis

Reply

Top Stories

ASX Market Update: Shares fall flat as GYG soars on debut | 20 June, 2024

STX

Strike Energy secures $153 million for Perth Basin gas projects

Plagues precede widespread power shifts. We’re living in one – and minerals are at the fore

BRX

Belararox delineates another porphyry in Argentina at Tambo South

With financials holding the fort, materials must step up with some heavy lifting to stimulate stocks

RDN

If you thought lithium was dead, think again. The Pilbara will be central to the next upswing

SBW

Shekel Brainweigh CEO Nir Leshem weighs in on AI adoption ahead of FY25

EMD

Emyria's Empax Centre chosen for mental health clinical trial

AML

Cultural heritage agreement puts Walford Creek exploration back on the map

FHE

Frontier Energy achieves key milestone for Waroona energy project

There are more pages in this discussion • 26 more messages in this thread...

First 5 Last

Add VLA (ASX) to my watchlist

I took some profit when SP went up to over $1 but still holding...

Top Stories

ASX Market Update: Shares fall flat as GYG soars on debut | 20 June, 2024

Strike Energy secures $153 million for Perth Basin gas projects

Plagues precede widespread power shifts. We’re living in one – and minerals are at the fore

Belararox delineates another porphyry in Argentina at Tambo South

With financials holding the fort, materials must step up with some heavy lifting to stimulate stocks

If you thought lithium was dead, think again. The Pilbara will be central to the next upswing

Shekel Brainweigh CEO Nir Leshem weighs in on AI adoption ahead of FY25

Emyria's Empax Centre chosen for mental health clinical trial

Cultural heritage agreement puts Walford Creek exploration back on the map

Frontier Energy achieves key milestone for Waroona energy project

Featured News